The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Dolgopolov I.S.

Tver State Medical University, Ministry of Health of Russia

Rykov M.Yu.

Tver State Medical University, Ministry of Health of Russia;
N.A. Semashko National Research Institute of Public Health

Mentkevich G.L.

Tver State Medical University, Ministry of Health of Russia

Chkadua G.Z.

N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia

Ryzhova M.V.

Burdenko Neurosurgical Center

Immunotherapy for a patient with high-grade glioblastoma

Authors:

Dolgopolov I.S., Rykov M.Yu., Mentkevich G.L., Chkadua G.Z., Ryzhova M.V.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2022;11(6): 37‑43

Views: 3777

Downloaded: 103


To cite this article:

Dolgopolov IS, Rykov MYu, Mentkevich GL, Chkadua GZ, Ryzhova MV. Immunotherapy for a patient with high-grade glioblastoma. P.A. Herzen Journal of Oncology. 2022;11(6):37‑43. (In Russ.)
https://doi.org/10.17116/onkolog20221106137

Recommended articles:
Early chemotherapy between surgery and radiotherapy in grade 4 gliomas. P.A. Herzen Journal of Onco­logy. 2024;(5):12-17
Patients with long-term survival in mali­gnant gliomas after photodynamic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):54-61
Claudin-18.2 and gastric cancer: from physiology to carcinogenesis. Russian Journal of Archive of Pathology. 2024;(6):92-99

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.